Please assess the completion status of the following clinical trial:

Trial Title: Short Term Refractive and Ocular Parameter Changes After Topical Atropine

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who had an SER of -0.5 diopters or less in their eyes.~Exclusion Criteria:~* Patients who had already been undergoing cycloplegic treatment for myopia before.

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- 0.125% atropine group (Type: EXPERIMENTAL): patients used the 0.125 % atropine eyedrop every night before sleep for 7 days

Based on this trial design, predict the completion outcome and termination type (if applicable).